Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements Of Changes In Stockholders??? Equity (Deficit) (Unaudited)

v3.25.1
Condensed Consolidated Statements Of Changes In Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock
Series B
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 54 $ 130,117,209 $ (2,901,339) $ (127,343,657) $ (127,733)
Balance (in Shares) at Dec. 31, 2023 534,719        
Shares issued from exercise of pre-funded warrants related to Amendment to August 2023 Offering $ 26 463 489
Shares issued from exercise of pre-funded warrants related to Amendment to August 2023 Offering (in Shares) 257,205        
Adjustment related to reverse stock split $ 6 (6)
Adjustment related to reverse stock split (in Shares) 60,848        
Stock-based compensation 236,062 236,062
Comprehensive loss:            
Net loss (1,069,744) (1,069,744)
Other comprehensive Income (Loss) 6,460 6,460
Balance at Mar. 31, 2024 $ 86 130,353,728 (2,894,879) (128,413,401) (954,466)
Balance (in Shares) at Mar. 31, 2024 852,772        
Balance at Dec. 31, 2024 $ 100 $ 318 153,691,755 (2,916,918) (141,523,344) 9,251,911
Balance (in Shares) at Dec. 31, 2024 1,000,000 3,176,999        
Cancelled shares
Cancelled shares (in Shares) (2,385)       (2,385)
Shares issued for settlement of liabilities $ 24 309,976 $ 310,000
Shares issued for settlement of liabilities (in Shares) 243,166        
Stock-based compensation $ 45 577,539 577,584
Stock-based compensation (in Shares) 450,000        
Conversion of Series B Convertible Preferred Stock $ (100) $ 132 (32)
Conversion of Series B Convertible Preferred Stock (in Shares) (1,000,000) 1,318,000        
Comprehensive loss:            
Net loss (2,369,232) (2,369,232)
Other comprehensive Income (Loss) (64,691) (64,691)
Balance at Mar. 31, 2025 $ 519 $ 154,579,238 $ (2,981,609) $ (143,892,576) $ 7,705,572
Balance (in Shares) at Mar. 31, 2025 5,185,780